Overview
HIMS market data
Price History
HIMS price chart
Valuation & Profitability
- P/E (TTM)
- 52.29 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $0.50 Diluted earnings per share over the trailing twelve months.
- Beta
- 2.43 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -0.6% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $13.74 – $65.30 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $6.7B · P/B 13.66 · P/S 2.83.
Company News
Citigroup Maintains Neutral on Hims & Hers Health, Lowers Price Target to $33Benzinga · Aug 11, 2026, 7:32 PM
Deutsche Bank Maintains Hold on Hims & Hers Health, Raises Price Target to $26Benzinga · Aug 11, 2026, 5:06 PM
B of A Securities Maintains Neutral on Hims & Hers Health, Raises Price Target to $32Benzinga · Aug 11, 2026, 4:48 PM
TD Cowen Maintains Hold on Hims & Hers Health, Raises Price Target to $30Benzinga · Aug 11, 2026, 4:02 PM
Morgan Stanley Maintains Equal-Weight on Hims & Hers Health, Raises Price Target to $28Benzinga · Aug 11, 2026, 3:42 PM
Hims & Hers Health: Investments Necessary For Long-Term Incremental Growth, Says Bullish AnalystBenzinga · Aug 11, 2026, 3:27 PM
Why Is Hims & Hers Health Stock Falling Tuesday?Benzinga · Aug 11, 2026, 1:16 PM
OppFi Posts Downbeat Q2 Earnings, Joins Upwork, Rocket Lab And Other Big Stocks Moving Lower In Tuesday’s Pre-Market SessionBenzinga · Aug 11, 2026, 12:04 PM
Hims & Hers Health shares are trading lower after the company reported mixed Q2 financial results.Benzinga · Aug 11, 2026, 11:57 AM
Needham Maintains Buy on Hims & Hers Health, Raises Price Target to $42Benzinga · Aug 11, 2026, 11:37 AM